Want to see DOCS full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026After Close (Confirmed)
Period Ending
2027 (Q1)Consensus EPS Forecast
0.3Last Year’s EPS
0.36Same Quarter Last Year
Moderate Buy
Based on 20 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlights strong financial health (record free cash flow, solid full-year revenue growth, high adjusted EBITDA and cash balance), robust engagement and rapid AI adoption across physicians and health systems, and meaningful early commercial traction for AI products. Offsetting these positives are near-term margin pressure from rising AI compute and investments, slower revenue guidance (~4% FY27 growth at midpoint), delayed AI monetization due to regulatory reviews, and softer bookings/visibility driven by policy and macro uncertainty. Management frames the year as an "AI investment year"—accepting short-term margin impact to capture a larger long-term TAM.Company Guidance
Record Free Cash Flow
Q4 free cash flow of $107 million (first-ever 9-digit FCF quarter) and full-year free cash flow of $317 million, up 19% year-over-year; free cash flow was 49% of revenue for fiscal 2026.
Revenue Growth
Q4 revenue $145 million, up 5% year-over-year; full fiscal year revenue $645 million, up 13% year-over-year.
Strong Adjusted EBITDA and Full-Year Profitability
Full-year adjusted EBITDA was $358 million (55% margin), up from $314 million last year (+14% year-over-year). Q4 adjusted EBITDA was $66 million with a 45% margin.
Healthy Customer Retention and Large Customer Cohort
Net revenue retention rate of 109% on a trailing 12-month basis; top 20 customers NRR of 114%. 125 customers contributed at least $500k in subscription revenue (up ~6% vs prior year) and accounted for 83% of total revenue.
Rapid Workflow & AI Engagement Growth
Benchmark workflow engagement exceeded 800,000 unique quarterly active prescribers in Q4, ~30% year-over-year acceleration from prior period; nearly half of active prescribers used Doximity AI tools in Q4.
Strong Early Traction for Acquired AI Product
Since acquiring Pathway, AI Search and Scribe active users tripled in 9 months; recent users averaged 31 queries per month (nearly double January); in a head-to-head clinical search evaluation, Doximity AI answers were preferred 2:1 by 4,700 physician residents.
Enterprise & Health System Adoption
140 health systems have purchased the clinical AI suite, including 7 of the top 20 hospitals; over 250,000 prescribers now have access to the clinical AI suite within hospital-approved, HIPAA-compliant workflows.
Strong Balance Sheet and Share Repurchase Activity
Ended year with $749 million in cash, cash equivalents and marketable securities. Repurchased $432 million of shares in fiscal 2026 (including $91 million in Q4) with $493 million remaining in the repurchase program.
Commercial Product Launches & Partnerships
Launched commercial AI Search product with early deals closed with top-20 pharma manufacturers; partnerships include Aledade for value-based care AI agents and Photon Health powering ePrescribing beta (1,000+ prescribers in beta).
Committed R&D & Talent Investments
380-person R&D team focused on physician-led features and agents; two senior hires announced (new CFO Matt Sonefeldt and President Dr. Steve Zatz) to bolster strategy and industry relationships.
DOCS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DOCS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $23.39 | $18.01 | -23.00% |
Feb 05, 2026 | $33.32 | $27.73 | -16.78% |
Nov 06, 2025 | $62.58 | $54.29 | -13.25% |
Aug 07, 2025 | $58.55 | $66.58 | +13.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Doximity, Inc. (DOCS) report earnings?
Doximity, Inc. (DOCS) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).
What is Doximity, Inc. (DOCS) earnings time?
Doximity, Inc. (DOCS) earnings time is at Aug 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DOCS EPS forecast?
DOCS EPS forecast for the fiscal quarter 2027 (Q1) is 0.3.
